Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic defibrillation.

Shue-ren Wann1, Max Harry Weil, Shijie Sun

  • 1Institute of Critical Care Medicine, Palm Springs, CA, USA.

Critical Care Medicine
|April 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ruthenium(II)-Catalyzed [2 + 1 + 3] Annulation of 3-Aryl-3-hydroxyisoindolinones with Diazopyrazolones: Step-Economical Synthesis of Spiro[1,3-oxazine-pyrazolones].

The Journal of organic chemistry·2026
Same author

HIgh versus STAndard blood Pressure target in hypertensive high-risk patients undergoing elective major abdominal surgery: the HISTAP multicenter randomized clinical trial.

Intensive care medicine·2026
Same author

Spatial transcriptomics reveals coordinated ventricular patterning and maturation in the developing human heart.

Nature communications·2026
Same author

Associations of Dietary Intake Traits and Aging Indicators With Colorectal Cancer: A Mendelian Randomization Study.

Genes, chromosomes & cancer·2026
Same author

Identification and pathogenicity validation of a novel MLH1 frameshift mutation in Lynch syndrome pedigree.

Gene·2026
Same author

In-Depth Plasma Proteomics Identifies SNCA as a Discriminating Biomarker of PDAC.

Journal of proteome research·2026

Cariporide, a sodium-hydrogen exchanger inhibitor, facilitated defibrillation in a rodent cardiac arrest model. This drug improved spontaneous defibrillation rates and survival, offering potential new strategies for cardiopulmonary resuscitation.

Area of Science:

  • Cardiology
  • Pharmacology
  • Emergency Medicine

Background:

  • Ventricular fibrillation (VF) is often sustained due to ion accumulation, increasing defibrillation difficulty.
  • Intracellular sodium and calcium overload during VF elevates the defibrillation threshold.
  • Cariporide inhibits the sodium-hydrogen exchanger, reducing intracellular sodium and calcium during ischemia.

Purpose of the Study:

  • To investigate if cariporide facilitates defibrillation from prolonged ventricular fibrillation.
  • To evaluate cariporide's efficacy in a rodent model of cardiac arrest and resuscitation.

Main Methods:

  • Fifteen rats received cariporide or placebo intravenously.
  • Ventricular fibrillation was induced and untreated for 8 minutes.
  • Cardiopulmonary resuscitation (CPR) was initiated for 8 minutes before attempted defibrillation.

Related Experiment Videos

Main Results:

  • Spontaneous defibrillation occurred in cariporide groups but not in placebo.
  • Successful resuscitation was observed in all but one placebo-treated animal.
  • Cariporide pretreatment significantly increased post-resuscitation survival duration.

Conclusions:

  • Sodium-hydrogen exchanger inhibition may enhance defibrillation success.
  • Cariporide shows promise for improving outcomes in cardiopulmonary resuscitation.
  • Further research into sodium-hydrogen exchanger inhibitors for resuscitation is warranted.